USPTO 2015–2025 USPTO PatentsView US Corporation

Stimwave Technologies Incorporated

USPTO PatentsView assignee record - 39 granted patents across 10 technology areas, recorded in grant years 2019–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy).

RSS updates for this company

The verdict

According to USPTO PatentsView, Stimwave ranks #8,293 of 49,997 tracked US assignees by granted-patent volume, with 39 patents across 10 technology areas.

#8,293
of 49,997 US assignees by volume
Top 44%
by Innovation Score (37.3/100)
18.5
avg claims per patent
+29%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8293 · US Corporation #8,293 · 39 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-SMALL 39 grants
  • UPPER-Q #8,293/49,997
  • PHOTO-FINISH SetPoint Medical
  • CPC-FOCUS A61N · 10 areas
  • INNOV-THIN 37.3/100
  • CLAIMS-RICH 18.5 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +29% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: SetPoint Medical Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Stimwave’s 37.3 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Stimwave

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Stimwave's Innovation Score is 37.3/100 (top 44% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Stimwave?

Each dot is one of Stimwave’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Stimwave’s own 18.5 claims/patent is ABOVE the 14.2 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Stimwave vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 38.939.039.03939.039.039.1 510152025 Granted patents (volume) Avg claims / patent SetPoint Medical Corporation - 39, 17.67Setpoint MedicalSingapore University of Technology and Design - 39, 16.44Singapore Univers…Slayback Pharma LLC - 39, 14.18Slayback PharmaSlice, Inc. - 39, 9.64SliceT-max (HANGZHOU) Technology, Co., Ltd. - 39, 15.44T-max (Hangzhou)…Thunder Power Hong Kong Ltd. - 39, 12.87Thunder Power Hon…TM IP Holdings, LLC - 39, 19.74TM IP HoldingsToyo Jidoki Co., Ltd. - 39, 13.28Toyo JidokiStimwave Technologies Incorporated - 39, 18.49Stimwave Incorpor…
Stimwave vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Stimwave's grants concentrate

Stimwave Technologies Incorporated is a focused PatentsView assignee: 10 CPC subclasses with 94.9% of grants classified under A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy). Peak complete grant year is 2019 (17 grants) versus a trough of 4 in 2020. By volume, Stimwave sits between SetPoint Medical Corporation and Toyo Jidoki Co., Ltd..

Stimwave's three-year grant acceleration

From 2019–2021 to 2022–2024, Stimwave Technologies Incorporated moved from 29 to 10 grants (0.34x the prior three-year total, a multiple, not a CAGR). See the growth leaderboard.

Who files at Stimwave's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Stimwave holds 39 patents at rank #8,292, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Stimwave

By rank, the assignees closest to #8,292 in granted patent volume.

Leaders in A61N (Electrotherapy)

Other assignees with the most granted patents in Stimwave's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Stimwave, neither rank-band nor same-CPC leaders (those blocks stay above). In A61N (Electrotherapy), Stimwave ranks #103 of 1,943 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Stimwave's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 44% higher than 56% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

05101520 20192020202120222023 4
USPTO utility patent grants by year · 2019–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.

View data table
Stimwave Technologies Incorporated patent grants by year, 2015–2025
Year Patents Granted Share of Period
2019 17 43.6%
2020 4 10.3%
2021 8 20.5%
2022 6 15.4%
2023 4 10.3%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Stimwave Technologies Incorporated's patent record in context - here's where to go next.

  • Stimwave Technologies Incorporated's lead technology class is A61N (ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy), 94.9% of its portfolio - see every assignee active in that class. Explore A61N
  • Ranked #8,293 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Stimwave Technologies Incorporated against SetPoint Medical Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 37.3/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.